To determine whether ANXA4 knockdown in clear cell carcinoma cells improved platinum sensitivity in vivo, NC7 and Y4 cells were subcutaneously injected in ICR nu/nu mice. The gene discussed is ANXA4; the disease is clear cell adenocarcinoma.